CCND3 Gene Amplification
1 clinical trials · Condition
◉ Watch CCND3 Gene Amplification
| Record | Firm | Date |
|---|---|---|
| Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer (NCT02785939) | SWOG Cancer Research Network | 2014-09-01 |
Track CCND3 Gene Amplification automatically
Every clearance here is in the API, with alerts when new ones post.